Clinical Trials Sponsored by Immunovative Therapies, Ltd.

Total 32 results

Immunovative Therapies, Ltd.

Completed

Safety and Tolerability Study of AlloVax(TM) in Patients With Metastatic or Recurrent Cancer of the Head and Neck (HNC)

Squamous Cell Carcinoma of the Head and Neck | Cancer of Head and Neck

Thailand
Immunovative Therapies, Ltd.

Terminated

Bioengineered Allogeneic Immune Cells (AlloStim) Not Requiring HLA Donor Match for Blood Cancers

Advanced or Refractory Leukemia, Lymphoma, Multiple Myeloma

United States
Immunovative Therapies, Ltd.

Withdrawn

In-Situ Therapeutic Cancer Vaccine for Refractory Liver Cancer

Hepatocellular Carcinoma

Israel
Immunovative Therapies, Ltd.

Withdrawn

Study Comparing AlloVax™ to Chemotherapy in Recurrent/Metastatic Squamous Cell Carcinoma of the Head & Neck

Squamous Cell Carcinoma Head and Neck

Thailand
Immunovative Therapies, Ltd.

Completed

AlloStim® Immunotherapy Dosing Alone or in Combination With Cryoablation in Metastatic Colorectal Cancer

Colorectal Cancer Metastatic

United States
Immunovative Therapies, Ltd.

Completed

An Individualized Anti-Cancer Vaccine in Advanced Hepatocellular Carcinoma Subjects

Advanced Adult Hepatocellular Carcinoma

Thailand
Immunovative Therapies, Ltd.

Withdrawn

An Individualized Anti-Cancer Vaccine Study in Patients With HCC

Hepatocellular Carcinoma

Israel
Immunovative Therapies, Ltd.

Withdrawn

Increased Frequency of AlloStim(TM) Dosing in Combination With Cryoablation in Metastatic Breast Cancer Patients (MBC)

Metastatic Breast Cancer

United States
Immunovative Therapies, Ltd.

Withdrawn

AlloStim® In-Situ Vaccine in Pre-Treated Metastatic Colorectal Cancer

Metastatic Colorectal Cancer

Thailand
Immunovative Therapies, Ltd.

Completed

In-Situ Therapeutic Cancer Vaccine for Metastatic Cancer Combining AlloStim With Tumor Cryoablation

Metastatic Cancer

United States
Immunovative Therapies, Ltd.
Mirror Biologics, Inc.

Completed

Universal Anti-Viral Vaccine for Healthy Elderly Adults (ALLOPRIME)

Virus Diseases | Pneumonia | Influenza, Human | COVID-19 Respiratory Infection | ARDS, Human | RSV Pneumonia

United States
Immunovative Therapies, Ltd.
Mirror Biologics, Inc.

Recruiting

Immunotherapy for Advanced Liver Cancer (ALIVE)

Hepatocellular Carcinoma

Thailand, Malaysia
Immunovative Therapies, Ltd.
Hadassah Medical Organization

Completed

A Phase I/II Study of Mis-Matched Immune Cells (AlloStim) in Patients With Advanced Hematological Malignancy

Lymphoma | Leukemia | Multiple Myeloma | Hematological Malignancy

Israel
Immunovative Therapies, Ltd.
Mirror Biologics, Inc.

Recruiting

Immunotherapy for Third Line Metastatic Colorectal Cancer (STIMVAX)

Metastatic Colorectal Cancer

United States
Michael Har-Noy
Hadassah Medical Organization

Completed

Experimental Therapeutic Cancer Vaccine Created In-situ in Patients With Stage II-Stage IV Cancer

Melanoma | Sarcoma | Breast Cancer | Colorectal Cancer | Ovarian Cancer | Prostate Cancer | Non-small Cell Lung Cancer | Solid Tumors Stage II, Stage III and Stage IV

Israel
Tissue Therapies Ltd.

Withdrawn

A Prospective Randomized, Double-Blind, Placebo-Controlled Trial Comparing VitroGro® ECM to Placebo in Patients With Venous Leg Ulcers

Venous Leg Ulcer
Therapex Co., Ltd

Not yet recruiting

A Study to Investigate Safety, Tolerability, PK and Anti-tumor Activity of TRX-221 in EGFRm NSCLC Patients

Carcinoma, Non-Small-Cell Lung | EGFR Mutant Advanced Non-Small Cell Lung Cancer
Axovant Sciences Ltd.

Terminated

Long-Term Extension Study of Intepirdine (RVT-101) in Subjects With Dementia With Lewy Bodies: HEADWAY-DLB Extension

Dementia With Lewy Bodies

United States, Canada, France, Italy, Netherlands, Spain, United Kingdom
Axovant Sciences Ltd.

Completed

Study Evaluating Intepirdine (RVT-101) on Gait and Balance in Subjects With Dementia

Alzheimer's Disease | Dementia With Lewy Bodies | Parkinson's Disease Dementia

United States
Axovant Sciences Ltd.

Completed

Study Evaluating Intepirdine (RVT-101) in Subjects With Mild to Moderate Alzheimer's Disease on Donepezil: MINDSET Study

Alzheimer's Disease

United States, Argentina, Australia, Bulgaria, Canada, Chile, Croatia, France, Germany, Italy, Korea, Republic of, Poland, Serbia, Singapore, Slovakia, Spain, Taiwan, United Kingdom, Czechia
Axovant Sciences Ltd.

Completed

Study Evaluating Nelotanserin for Treatment of Visual Hallucinations in Subjects With Lewy Body Dementia

Lewy Body Dementia | Visual Hallucinations

United States
Axovant Sciences Ltd.

Completed

Study Evaluating Nelotanserin for Treatment of REM Sleep Behavior Disorder in Subjects With Dementia (DLB or PDD)

REM Sleep Behavior Disorder | Dementia With Lewy Bodies | Parkinson's Disease Dementia

United States
Axovant Sciences Ltd.

Terminated

12-Month Open-Label Extension Study of Intepirdine (RVT-101) in Subjects With Alzheimer's Disease: MINDSET Extension

Alzheimer's Disease

United States, Argentina, Australia, Bulgaria, Canada, Chile, Croatia, Czechia, France, Germany, Italy, Korea, Republic of, Poland, Serbia, Singapore, Slovakia, Spain, Taiwan, United Kingdom
Axovant Sciences Ltd.

Completed

Study Evaluating Intepirdine (RVT-101) in Subjects With Dementia With Lewy Bodies: The HEADWAY-DLB Study

Dementia With Lewy Bodies

United States, Canada, France, Italy, Netherlands, Spain, United Kingdom
Axovant Sciences Ltd.

Terminated

Open-label Study of Nelotanserin in Lewy Body Dementia With Visual Hallucinations or REM Sleep Behavior Disorder

REM Sleep Behavior Disorder | Dementia With Lewy Bodies | Lewy Body Dementia | Parkinson's Disease Dementia | Visual Hallucinations

United States
Fudan University
Shanghai Regenelead Therapies Co., Ltd.

Not yet recruiting

Study of Personalized Tumour Vaccines and a PD-L1 Blocker in Patients With Surgically Resected Pancreatic Adenocarcino

Pancreatic Cancer

China
Axovant Sciences Ltd.
Oxford BioMedica

Terminated

Long Term Safety and Efficacy Study of ProSavin in Parkinson's Disease

Parkinson's Disease

France, United Kingdom
LTS Lohmann Therapie-Systeme AG

Completed

Magnetic Marker Monitoring of Furosemide-containing Gastroretentive Formulation in Healthy Male Subjects (Fasting and Fed Conditions)

Gastroretentive Drug Formulation of Furosemide | Oedema

Germany
THERAPIM PTY LTD
Novotech (Australia) Pty Limited

Terminated

A Study to Evaluate the Combination of ATX-101 and Platinum-based Chemotherapy

Ovarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Carcinoma | High Grade Serious or Endometrioid Carcinoma of the Ovary, Fallopian Tube, or Primary Peritoneal Cancer

Australia
Second Affiliated Hospital of Soochow University
Shanghai Regenelead Therapies Co., Ltd.

Recruiting

A Study on the Safety and Tolerability of RGL-193 in Patients With Advanced Parkinson's Disease

Advanced Parkinson's Disease

China
Ixaka Ltd
Andalusian Network for Design and Translation of Advanced Therapies

Terminated

The Efficacy and Safety of REX-001 to Treat Ischemic Ulcers in Subjects With CLI Rutherford Category 5 and DM

Cardiovascular Disease | Diabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1 | Critical Limb Ischemia (CLI) | Peripheral Arterial Disease (PAD) | Diabetes Mellitus (DM)

Spain, Netherlands, United Kingdom, Czechia, Portugal, Hungary
Ixaka Ltd
Andalusian Network for Design and Translation of Advanced Therapies

Terminated

The Efficacy and Safety of REX-001 to Treat Ischemic Rest Pain in Subjects With CLI Rutherford Category 4 and DM

Cardiovascular Disease | Diabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1 | Critical Limb Ischemia (CLI) | Peripheral Arterial Disease (PAD) | Diabetes Mellitus (DM)

Spain, Czechia, Portugal, Hungary, Germany, Poland

Clinical Trials Sponsored by Immunovative Therapies, Ltd.

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Tanzania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations